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Metastatic cancer cells have the ability to both degrade and migrate through the extracellular matrix (ECM). Invasiveness
can be correlated with the presence of dynamic actin-rich membrane structures called podosomes or invadopodia. We
showed previously that the adaptor protein tyrosine kinase substrate with five Src homology 3 domains (Tks5)/Fish is
required for podosome/invadopodia formation, degradation of ECM, and cancer cell invasion in vivo and in vitro. Here,
we describe Tks4, a novel protein that is closely related to Tks5. This protein contains an amino-terminal Phox homology
domain, four SH3 domains, and several proline-rich motifs. In Src-transformed fibroblasts, Tks4 is tyrosine phosphory-
lated and predominantly localized to rosettes of podosomes. We used both short hairpin RNA knockdown and mouse
embryo fibroblasts lacking Tks4 to investigate its role in podosome formation. We found that lack of Tks4 resulted in
incomplete podosome formation and inhibited ECM degradation. Both phenotypes were rescued by reintroduction of
Tks4, whereas only podosome formation, but not ECM degradation, was rescued by overexpression of Tks5. The tyrosine
phosphorylation sites of Tks4 were required for efficient rescue. Furthermore, in the absence of Tks4, membrane type-1
matrix metalloproteinase (MT1-MMP) was not recruited to the incomplete podosomes. These findings suggest that Tks4
and Tks5 have overlapping, but not identical, functions, and implicate Tks4 in MT1-MMP recruitment and ECM
degradation.
INTRODUCTION
In recent years, there has been increasing interest in defining
the mechanisms by which cancer cells acquire invasive be-
havior. In particular, dynamic membrane structures called
podosomes or invadopodia have been shown to play an
important role in invasive cell motility and extracellular
matrix (ECM) degradation (reviewed in Linder, 2007;
Gimona et al., 2008). Invadopodia are actin-rich membrane
protrusions that coordinate the cytoskeleton with extracel-
lular proteolysis. Invadopodia have been found in many
different types of invasive human cancer cells, and they are
particularly well studied in breast cancer and melanoma as
well as Src-transformed fibroblasts, in which they were first
discovered (Chen et al., 1985; Tarone et al., 1985; Chen and
Wang, 1999).
Several normal cell types whose physiological roles re-
quire motility and ECM degradation can also form podo-
somes (Linder and Aepfelbacher, 2003). This list includes
osteoclasts, macrophages, endothelial cells, and vascular
smooth muscle cells. Current convention is to call the struc-
tures that exist in normal cells and in Src-transformed cells
podosomes, and to use the term invadopodia for those struc-
tures found in invasive cancer cells (Gimona et al., 2008).
Although some investigators have noted structural differ-
ences between podosomes and invadopodia, few molecular
differences have been described. This leaves open the pos-
sibility that differences in culture conditions may influence
podosome/invadopodia architecture and function. Indeed,
a recent article reported that extracellular matrix rigidity
influences both the number and activity of invadopodia
(Alexander et al., 2008). Our understanding of the protein
components of podosomes and invadopodia has deepened
in recent years, and we are also beginning to learn the
signals that promote the formation and turnover of these
structures. Ultimately, the study of both podosomes and
invadopodia may yield new targets for cancer therapeutics.
Many of the original studies on podosomes/invadopodia
were conducted in Src-transformed fibroblasts, and this con-
tinues to be a rich model system to study their structure and
function. These cells are highly invasive both in vitro and in
vivo, and the podosomes are abundant and arranged in
characteristic rings known as rosettes. Furthermore, several
lines of evidence point to a physiological role for Src in both
podosome and invadopodia formation. For example, mice
lacking Src develop osteopetrosis because of a podosome
defect of osteoclasts (Soriano et al., 1991; Boyce et al., 1992;
Lowe et al., 1993). The transforming growth factor-–stimu-
lated podosome formation seen in aortic endothelial cells
requires Src (Varon et al., 2006). And Src is also required for
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invadopodia formation in human breast cancer cells (Artym
et al., 2006; Cortesio et al., 2008). In keeping with a role for Src
in podosome/invadopodia formation, many Src substrates
are obligate podosome components, including cortactin,
AFAP110, paxillin, p130Cas, ASAP1, and dynamin (Baldas-
sarre et al., 2003; Brabek et al., 2004; Gatesman et al., 2004;
Webb et al., 2006; Bharti et al., 2007; Clark et al., 2007; Badowski
et al., 2008).
Some years ago, we cloned a new Src substrate, and we
showed that it localized to podosomes of Src-transformed
fibroblasts (Lock et al., 1998; Abram et al., 2003). We origi-
nally called this protein Fish, but we now designate it as
tyrosine kinase substrate with five Scr homology 3 (SH3)
domains (Tks5, gene symbol SH3PXD2A), Tks5 is a large
adaptor or scaffold protein with an amino-terminal Phox
homology or PX domain, and five SH3 domains. It also
contains several proline-rich motifs and at least two Src
phosphorylation sites. Our subsequent experiments using
short hairpin RNA (shRNA)-mediated reduction in Tks5
expression in Src-transformed fibroblasts (Src-3T3) showed
that it is required for podosome formation, ECM degrada-
tion, and invasion through Matrigel (Seals et al., 2005). We
also found that Tks5 is overexpressed in several human
cancer cell lines and tissues. Knockdown of Tks5 in mela-
noma and breast cancer cells results in decreased protease-
dependent invasion. Furthermore, expression of Tks5 in a
noninvasive breast cancer cell line results in the formation of
invadopodia (Seals et al., 2005). Together, these data suggest
that Tks5 is an essential scaffold protein of podosomes/
invadopodia. We went on to test the tumorigenicity of Src-
3T3 cells with and without Tks5 knockdown (Blouw et al.,
2008). We found that tumor growth of the Tks5 knockdowns
is inhibited regardless of whether tumor cells are introduced
subcutaneously or intravenously (to give rise to experimen-
tal lung metastases). The most obvious defects in the tumors
arising from the knockdown cells is a poorly developed
tumor vasculature. These data are consistent with a role of
Tks5, and perhaps by implication, podosomes/invadopo-
dia, in tumor growth in vivo. We are currently investigating
whether Tks5 is required for proteolytic processing of vas-
cular growth factors in the tumor microenvironment.
Because Tks5 has no catalytic activity, it is likely to act by
bringing together key regulators of podosomes/invadopo-
dia. We have shown previously that its PX domain, which
binds phosphatidylinositol-3,4-bisphosphate (PI-3,4P2) and
phosphatidylinositol-3-phosphate (PI 3-P), is required for
the generation of podosomes/invadopodia (Abram et al.,
2003). The fifth SH3 domain of Tks5 binds the transmem-
brane metalloproteases ADAMs 12, 15, and 19 (Abram et al.,
2003). More recently, it was shown that accumulation of
PI-3,4P2 at focal adhesions results in the recruitment of a
Tks5–Grb2 complex (Oikawa et al., 2008). Subsequent bind-
ing of neural Wiskott Aldrich syndrome protein (N-WASp)
to Tks5 facilitates formation of rosettes of podosomes in
Src-transformed fibroblasts.
When we originally cloned Tks5, which is encoded by the
SH3PXD2A gene on human chromosome 10, a search of
available databases revealed no closely homologous se-
quences. The nearest relative to Tks5 was p47phox, a com-
ponent of the NADPH oxidase system of phagocytic cells,
which has one PX domain and two SH3 domains, arranged
in a similar orientation to Tks5. More recently, however, in
a search of cDNA databases we found a sequence (derived
from a mouse dendritic cell cDNA library) that more closely
resembled Tks5 and that we called Tks4 (Courtneidge et al.,
2005). Here, we describe our identification and initial char-
acterization of this gene product.
MATERIALS AND METHODS
Cloning of Tks4
To search for Tks5-related genes, a homology BLAST search of public databases
was performed using the human Tks5 protein sequence. A human cDNA,
FLJ46896 (clone UTERU3021231), was identified that had significant homology to
the human Tks5 transcript. This cDNA encoded a hypothetical protein (accession
no. LOC285590) that also had significant homology to the Tks5 protein. Subse-
quently, this hypothetical gene product has been annotated as SH3 and PX
domains 2B (SH3PXD2B), with the putative human gene product NM_014631
and the putative mouse gene product NM_177364. Mouse RNA was purified
from low passage NIH-3T3 cells by using TRIzol (Invitrogen, Carlsbad, CA)
nucleotide extraction, and adult brain RNA was obtained from Stratagene (La-
Jolla, CA). SuperScript II reverse transcriptase (Invitrogen) was used to generate
mouse and human oligo(dT)-primed cDNA according to the manufacturer’s
instructions. To clone the full-length transcript, oligonucleotides were designed
and used to amplify the appropriate full-length transcript from mouse as well as
human cDNA by using Phusion DNA polymerase (New England Biolabs,
Ipswich, MA). Polymerase chain reaction (PCR) products were then cloned
into pCR2.1-TOPO vector (Invitrogen), and multiple clones sequenced and
analyzed. The human and mouse Tks4 clones were 100% identical in
sequence to human and mouse SH3PXD2B, respectively.
Antibodies
Tks4–glutathione transferase (GST) fusion constructs were synthesized by
PCR using oligonucleotides containing specific restriction endonuclease sites.
PCR products were cloned into pGEX bacterial expression plasmids (GE
Healthcare, Piscataway, NJ), and plasmids were sequenced. Constructs were
transformed into the BL21 (DE3) strain of Escherichia coli (Stratagene, La Jolla,
CA). Tks4–GST fusion protein expression was induced with 1 mM isopropyl
-d-thiogalactoside for 3 h at 37°C. Shaking flask cultures were centrifuged at
6000  g at 4°C for 15 min to pellet bacteria. Bacterial pellets were suspended
in lysis buffer (phosphate-buffered saline [PBS] plus 0.1% Triton X-100, 1 mM
dithiothreitol [DTT], 1 mM phenylmethylsulfonyl fluoride, and Complete
protease inhibitor cocktail [Roche Diagnostics, Indianapolis, IN]) and soni-
cated for 1 min at 4°C. Lysates were centrifuged at 20,000  g for 30 min at
4°C, and supernatants were collected. Tks4-GST in supernatants was purified
using glutathione-Sepharose (GE Healthcare) affinity chromatography, and
Tks4-GST was eluted using PBS with 10 mM reduced glutathione.
Two Tks4-specific antisera were generated in rabbits and affinity purified
by Millipore Bioscience Research Reagents (Temecula, CA). Tks4-A was gen-
erated by immunizing rabbits with a purified mouse Tks4–GST fusion pro-
tein, corresponding to amino acids 257-477 (09-260; Millipore Bioscience
Research Reagents). Tks4-B was generated by immunizing rabbits with a
purified human Tks4 GST fusion protein, corresponding to amino acids
431-595 (09-267; Millipore Bioscience Research Reagents). Tks5 antibodies
have been described previously (Lock et al., 1998). The following commercial
antibodies were used: anti-cortactin (4F10), anti-phosphotyrosine (4G10), and
anti-membrane type-1 matrix metalloproteinase (MT1-MMP) (Millipore Bio-
science Research Reagents); anti-FLAG (M2), and anti-vinculin (hVIN-1) (Sig-
ma-Aldrich, St. Louis, MO); and anti-green fluorescent protein (GFP) (Invitro-
gen). Alexa Fluor 680 goat anti-rabbit or anti-mouse antibodies were used for
immunoblot analysis, and Alexa Fluor 488 or 594 goat anti-rabbit or anti-
mouse antibodies and Alexa Fluor 488 or 564 phalloidin were used for
immunofluorescence microscopy (Invitrogen).
Cell Culture and Transfection
NIH-3T3 (3T3) and Src-transformed NIH-3T3 (Src-3T3) cells have been de-
scribed previously (Lock et al., 1998). Stable Tks4 knockdown Src-3T3 cells
were created using the Mission shRNA vector TRCN0000105931 (Sigma-
Aldrich). Src-3T3 cells were transfected with shRNA vectors by using calcium
phosphate transfection. Drug-resistant colonies were selected for and main-
tained in media containing 10 g/ml puromycin. Primary mouse embryonic
fibroblasts (MEFs) were isolated from wild-type and Tks4/ day e13 mouse
embryo littermates derived from embryonic stem cells containing a gene trap
in the Tks4 locus (Lexicon, The Woodlands, TX). The abdominal organs and
brain were dissected out for genotyping, whereas the remaining embryo was
digested in 0.05% trypsin-EDTA and then washed and plated in DMEM
containing 10% fetal bovine serum. Src-transformed MEFs (Src-MEFs) were
created using pBABE-puro SrcY530F retrovirus infection (Morgenstern and
Land, 1990) of passage 1 or 2 MEFs and selected for using 5 g/ml puromy-
cin. Early passage B16-F10 mouse melanoma cells were a gift from Peter Lock
(La Trobe University, Melbourne, Australia). These cells were transfected
with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s proto-
col. All cells were maintained in DMEM (Mediatech, Manassas, VA) contain-
ing 10% fetal bovine serum and antibiotics in 10% CO2.
Constructs
All point mutations were introduced to Tks4 constructs by using QuikChange
II site-directed mutagenesis (Stratagene). The active Src pSGT-SrcY527F con-
struct has been described previously (Erpel et al., 1995). Lentiviruses encoding
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Tks4 and Tks5 were created by subcloning Tks4-GFP or Tks5-GFP from
pEGFP-N1 constructs to SIN18.hPGK lentivirus vector. Lentiviral prepara-
tions were made by the virus core facility at the Burnham Institute for Medical
Research (La Jolla, CA).
Expression Profiling
Quantitative-PCR (Q-PCR) primers were designed using Primer3 web-based
analysis software and obtained from Integrated DNA Technologies DNA (San
Diego, CA). Specificity of Q-PCR primers was verified by amplifying serial
10-fold dilutions of cDNA from NIH3T3 cells and resolving PCR products by
using agarose gel electrophoresis. All oligonucleotides amplified a single
band of the correct molecular weight across all dilutions. The Mouse MTC
Multiple Tissue cDNA Panel I (Clontech, Mountain View, CA) was used as
template for Q-PCR tissue expression profiling. TRIzol (Invitrogen) nucleo-
tide extraction was used to isolate RNA from NIH-3T3 and Src-3T3 cells, and
oligo(dT)-primed cDNA was generated using SuperScript II reverse transcrip-
tase (Invitrogen). Q-PCR was performed using the SYBR-Green PCR Master
Mix (Applied Biosystems, Foster City, CA) on an MX3000 real-time PCR
thermal cycler (Stratagene). Transcript levels were determined by analyzing
Ct data, and relative mRNA expression levels were determined by compar-
ison with transcript levels in NIH-3T3 cDNA.
Immunoprecipitation and Immunoblot Analysis
Cell lysates were prepared by washing cells twice with cold Tris-buffered
saline (TBS) containing 100 M Na3VO4 and 2 mM DTT and then lysed in 50
mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 10 mM NaF, 100 M
Na3VO4, and 2 mM DTT lysis buffer containing dissolved complete Mini
protease inhibitor tab (Roche Diagnostics). For immunoprecipitations, protein
extracts were incubated with 1 l of antibody or antiserum and 15 l of
packed protein A-Sepharose beads (Sigma-Aldrich) or protein G-agarose
beads (Calbiochem, San Diego, CA) for 60 min at 4°C. Immunocomplexes
were then washed five times in lysis buffer and once in TBS containing 100
M Na3VO4 and 2 mM DTT. Extracts were then eluted from beads by using
SDS sample buffer, boiled for 5 min, and separated by SDS-polyacrylamide
gel electrophoresis (PAGE) on 7.5 or 10% Criterion gels (Bio-Rad, Hercules,
CA). SDS-PAGE gels were then transferred to Hybond nitrocellulose mem-
branes (GE Healthcare) by using TransBlot SD semidry transfer system
(Bio-Rad).
Immunofluorescence Microscopy
Cells were grown for 20 h on glass coverslips. Cells were then fixed with 4%
paraformaldehyde/PBS (Electron Microscopy Sciences, Hatfield, PA) for 20
min, permeabilized with 0.1% Triton X-100/PBS for 10 min, and blocked with
2.5% goat serum. Fixed cells were incubated with primary antibodies for 1 h,
extensively washed with PBS, and incubated with secondary antibodies and
phalloidin for 30 min. Coverslips were mounted using VECTASHIELD (Vec-
tor Laboratories, Burlingame, CA). All images were captured on an Axio-
plan-2 fluorescence microscope with an AxioCam HRm camera and were
analyzed with Axiovision 3.0 software (Carl Zeiss, Thornwood, NY), except
for Figure 7, B and C, for which confocal microscopy was used.
ECM Assay
Fluorescently labeled gelatin-coated coverslips were prepared as described
previously (Blouw et al., 2008). Cells were incubated on labeled coverslips for
3–20 h and either fixed with 4% paraformaldehyde/PBS at room temperature
for 20 min or with methanol for 5 min at 20°C.
Zymography
Conditioned media samples were prepared as described previously (Seals et
al., 2005) and analyzed on 10% gelatin zymogram gels (Invitrogen) according
to the manufacturer’s protocol.
Protein–Lipid Overlay
Protein–lipid overlay assays were performed as described previously (Dowler
et al., 1999; Abram et al., 2003) by using phosphoinositide (PIP) assays from
Echelon Biosciences (Salt Lake City, UT).
RESULTS
Tks4, a New Member of the Tks Family of Adaptor
Proteins
After our initial finding of a cDNA with sequence similarity
to Tks5 from a mouse dendritic cell library (Courtneidge et
al., 2005), we used public gene database searches to identify
further cDNAs in both mouse and human libraries. Genomic
databases were also used to map the gene to human chro-
mosome 5, and mouse chromosome 11. The gene has now
been given the symbol SH3PXD2B. It encodes a theoretical
protein with one PX domain and four SH3 domains (Figure
1), which we propose to call Tks4, for tyrosine kinase sub-
Figure 1. Topology and expression of Tks4.
(A) The structures of Tks4 and Tks5 are shown.
Dark gray boxes denote PX domains, and light
gray boxes are SH3 domains. Proline-rich mo-
tifs are shown as PxxP, and phosphotyrosines
as pY. (B) Tks4 mRNA levels were measured in
a variety of mouse tissue samples by Q-PCR.
Results are expressed relative to a value of 1 for
3T3 cells. (C) Tks4 and Tks5 mRNA levels were
measured in 3T3 and Src-3T3 cells, by using 3T3
cells as the reference.
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strate with four SH3 domains. Both Tks4 and Tks5 genes can
be found in several species from fish (Danio rerio) to human.
In simpler deuterostomes, however, there seems to be a
single Tks gene. In the tunicate Ciona intestinalis this gene
encodes a protein with one PX domain and three SH3 do-
mains, whereas in the sea urchin Strongylocentrotus purpura-
tus the predicted product has one PX domain followed by
four SH3 domains. Neither gene was found in organisms
such as flies and worms. We subsequently cloned Tks4 from
both a mouse NIH-3T3 cell and a human brain cDNA li-
brary, by using a PCR-based approach. The sequences of
both clones closely matched the sequences in the databases.
When comparing the human genes, the overall identity
between Tks4 and Tks5 is 43%. The PX domains share 77%
identity, the first SH3 domains are 81% identical, the second
are 68% identical, and the third are 70% identical. The fourth
SH3 domain of Tks4 is most similar to the fifth SH3 domain
of Tks5 (57% identity). The sequences between the SH3
domains, collectively called the linker sequences, are poorly
conserved with only 12% overall identity. Thus, Tks4 most
resembles Tks5 in its PX domain and SH3 domains. The
fourth SH3 domain and surrounding linker sequences of
Tks5 are not conserved in Tks4: in their place, Tks4 has a
longer linker with several polyproline-rich motifs.
We used quantitative-PCR analysis on mouse tissues and
cell lines to confirm that this hypothetical gene was tran-
scribed. We found the highest transcript levels in embryonic
samples, but there was also detectable expression in adult
organs, including heart, spleen, brain, skeletal muscle, kid-
ney, and liver. Both Tks4 and Tks5 were expressed in NIH-
3T3 (3T3) cells, with Src transformation increasing the
amount of each transcript three- to fivefold (Figure 1).
We next generated GST fusion proteins of linker se-
quences to use for the generation of antibodies. For the
mouse gene, the linker between the second and third SH3
domains was used (Tks4-A). For the human sequence, we
used the long linker between the third and fourth SH3
domains (Tks4-B). Antibodies were generated in rabbits and
affinity purified by Millipore Bioscience Research Reagents.
The antibodies were first tested on epitope-tagged Tks4
constructs and shown to both immunoprecipitate and im-
munoblot the transiently transfected protein (Figure 2). Note
that Tks4, which has 911 amino acids and a predicted mo-
lecular mass of 101,553 Da, ran on SDS-polyacrylamide gels
with an apparent molecular mass of 120 kDa. We also de-
termined whether the antibodies could recognize endoge-
nous protein. As shown in Figure 2, the antibodies also
recognized a protein of 120 kDa from 3T3 cells. Presumably
because of the sequence conservation between mouse and
human Tks4 (90% in the linker between the second and third
SH3 domains, 75% for that between third and fourth do-
mains), both A and B antibodies recognized the mouse and
human protein, both by immunoblotting and immunopre-
cipitation.
Phosphorylation and Lipid Binding Properties of Tks4
We have previously shown that Tks5 is a Src substrate,
whose PX domain binds in vitro to the lipids PI 3-P and PI
3,4P2 (Abram et al., 2003). To determine whether Tks4 had
similar properties, we first determined its phosphorylation
status in vivo (Figure 3). We detected tyrosine phosphory-
lation of Tks4 in the Src-3T3 cells compared with parental
3T3s. Furthermore, coexpression of Src and Tks4 by tran-
sient transfection resulted in robust phosphorylation of
Tks4, suggesting that it might be a direct substrate of Src. To
map the tyrosine phosphorylation sites, we used site-di-
Figure 2. Molecular nature of Tks4 and antibody characterization.
(A) Tks4-FLAG or empty-FLAG constructs were expressed in B16-
F10 cells by transient transfection. Tks4-FLAG protein was immu-
noprecipitated with M2 anti-FLAG antibody and analyzed by SDS-
PAGE and immunoblot analysis with Tks4-specific antisera. (B)
Endogenous Tks4 protein was immunoprecipitated with either
Tks4-A or Tks4-B antiserum from 3T3 cells and detected with a
mixture of Tks4-A and Tks4-B antisera.
Figure 3. Tks4 can be tyrosine phosphorylated and its PX domain
binds phosphatidylinositols. (A) Endogenous Tks4 protein was im-
munoprecipitated with Tks4-A antisera from B16-F10, 3T3, and
Src-3T3 cells, analyzed by SDS-PAGE, and immunoblotted with a
phosphotyrosine antibody. (B) Tyrosine-to-phenylalanine muta-
tions were introduced into Tks4-FLAG by site-directed mutagene-
sis. Mutant and wild-type Tks4-FLAG constructs were coexpressed
with Src in B16-F10 cells by transient transfection. Tks4-FLAG pro-
tein was immunoprecipitated with M2 anti-FLAG antibody, sepa-
rated by SDS-PAGE, and detected by immunoblot analysis with
anti-phosphotyrosine antibody. (C) Protein–lipid overlay assays
were performed on a PIP array with GST-Tks4 PX domain fusion
proteins. The phosphatidylinositols indicated are spotted left to
right at doubling dilutions from 100 to 1.56 pmol/spot.
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Figure 4. Tks4 localizes to podosomes and is required for their formation and function. (A) 3T3 were plated on glass coverslips for 20 h, fixed,
and stained with Tks4 antiserum (green) and phalloidin (red). Bars, 50 M. (B) Src-3T3 cells were plated on glass coverslips for 20 h,
fixed, and stained with Tks4 antiserum (green) and phalloidin (red). Arrows point to examples of rosettes of podosomes in Src-3T3 cells. Bars,
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rected mutagenesis to mutate several candidate tyrosine
residues, coexpressed the constructs with Src, immunopre-
cipitated, and probed for phosphotyrosine. Phosphorylation
was reduced when tyrosines 25, 373, and 508 were individ-
ually mutated to phenylalanine, and essentially absent when
the mutations were combined. Interestingly, tyrosine 25 is in
the PX domain and is also described as a phosphorylation
site by Phosphosite (www.phosphosite.org). Tyrosine 373 at
the amino terminus of the third SH3, and tyrosine 508, in the
long linker between the third and fourth SH3 domains, is in
a canonical Src SH2 domain binding sequence (YEEI). De-
spite this, we have been unable to detect an association
between Src and Tks4 in cells (unpublished observations).
To determine the lipid binding specificity of the Tks4 PX
domain, it was fused to GST, expressed in bacteria, purified,
and used to probe nitrocellulose filters spotted with phos-
phatidylinositol lipids (Figure 3). We observed a very simi-
lar binding affinity to Tks5, with PI 3-P and PI 3,4P2 being
the preferred lipids, and some association with phosphatidic
acid (data not shown).
The Subcellular Localization of Tks4
We used immunofluorescence microscopy to determine the
subcellular localization of Tks4 (Figure 4). In 3T3 cells, most
cells had a uniform cytoplasmic distribution of Tks4. The
occasional cell had more punctate staining. Markers for mi-
tochondria, late endosomes and Golgi failed to fully colo-
calize with these puncta. Future studies will assess whether
the distribution of Tks4 changes with the cell cycle and also
further evaluate the nature and significance of this punctate
staining. Transformation of 3T3 cells by the activated Src
oncogene leads to a dramatic reorganization of the actin
cytoskeleton and the formation of rosettes of podosomes. By
comparing the localization of F-actin, a known marker for
podosomes, and Tks4, we found that the majority of Tks4
was localized to the podosomes of Src-3T3 cells. In this
regard then, Tks4 is very similar to Tks5, which is localized
to, and required for the formation of, podosome formation
and function (Seals et al., 2005).
A Role for Tks4 in Podosome Formation and Function
To address the role of Tks4 in podosome formation, we first
created Src-3T3 cells stably expressing a shRNA specific for
Tks4, and we compared them to cells expressing the empty
shRNA vector. We achieved 90% knockdown of Tks4; this
resulted in an equivalent loss of podosome formation (Fig-
ure 4). Furthermore, degradation of fluorescent films of gel-
atin, a hallmark of podosome function, was also inhibited in
the knockdown cells. Although these data are strongly sup-
portive of a role for Tks4 in podosome formation and func-
tion, we were only able to identify a single shRNA sequence
that could effectively reduce Tks4 levels; thus, we could not
rule out off target effects. We therefore also took an alterna-
tive approach. We isolated primary fibroblasts from mice
homozygous for a gene trap in the third intron of Tks4 as
well as from wild-type and heterozygous littermates, in-
fected them with a retrovirus encoding activated Src, and
tested pools of cells for podosome formation. The Src-ex-
pressing wild-type (and heterozygous) MEFs exhibited ro-
bust podosome formation (Figure 5). In contrast, the cells
homozygous for the gene trap (Tks4/, which completely
lack Tks4 protein expression) had a distinct morphology,
and they failed to elaborate podosomes as determined by
F-actin staining. However, despite the lack of actin staining,
ventral membrane puncta were visualized by staining for
the other podosome markers Tks5, cortactin, vinculin, and
phosphotyrosine. These data might suggest that, in the ab-
sence of Tks4, podosome formation is incomplete. In keep-
ing with this, the Tks4/ Src-MEFs were unable to degrade
fluorescein isothiocyanate (FITC) gelatin, whereas their
wild-type counterparts were competent to degrade. To de-
termine whether the changes we saw in podosome forma-
tion were due to the acute loss of Tks4, rather than devel-
opmental changes in cells derived from Tks4 null mice, we
reintroduced Tks4 by infection with a lentivirus encoding
Figure 4 (cont). 50 M. (C) Cell lysates from Tks4 shRNA knock-
down cells and control shRNA cells were analyzed by SDS-PAGE
and immunoblotting with Tks4 antisera. (D) Control and Tks4
knockdown cells were plated on glass coverslips for F-actin (podo-
some) staining. White arrows point to examples of rosettes of po-
dosomes. One representative image of each cell line is shown. Bars,
50 M. (E) Quantification of the percentage of cells with rosettes of
podosomes from the experiment is shown in D. A minimum of 500
cells were counted from three coverslips. (F) Control and Tks4
knockdown cells were plated on Oregon Green 488 gelatin-coated
coverslips for detection of ECM degradation. Bars, 50 M. (G)
Quantification of the degradation of gelatin per cell from the exper-
iment shown in F. Error bars are SEM.
Figure 5. Tks4 null Src-MEFs fail to make functional podosomes.
(A) Cell lysates from Src-transformed Tks4/ and Tks4/ MEFs
were analyzed by SDS-PAGE and immunoblotting with Tks4 anti-
sera. (B) Src-transformed Tks4/ MEFs were plated on glass cov-
erslips for 20 h, fixed, and stained for the following podosome
markers: cortactin, Tks5, phosphotyrosine, vinculin, and F-actin.
Bars, 50 M. (C) Src-transformed Tks4/ MEFs were plated on
glass coverslips for 20 h, fixed, and stained for cortactin and F-actin.
Bars, 50 M.
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Tks4-GFP fusion protein (Figure 6). This treatment restored
full podosome formation, as judged by staining for F-actin,
as well as FITC-gelatin degradation, in 89% of the infected
cells. Together, the results of the shRNA knockdown and the
experiments with the Tks4/ Src-MEFs, strongly suggest
that Tks4 is required for functional podosome formation.
Tks4 and Tks5 are very similar adaptor proteins, and both
are expressed in Src-3T3 cells and Src-MEFs. We therefore
questioned whether they had redundant functions in podo-
some formation and function. In this scenario, the pheno-
types we see in the Tks4 and Tks5 knockdown cells would
be due to an overall reduced expression of Tks adaptor
proteins. To test this, we increased the expression of Tks5 in
the Tks4/ cells by infecting them with a lentivirus ex-
pressing Tks5-GFP (Figure 6). This was sufficient to restore
mature podosome formation in these cells, suggesting that
these two proteins might indeed have somewhat overlap-
ping functions in recruitment of actin regulators. However,
despite the presence of rosettes of podosomes, these cells
were not able to degrade FITC-gelatin, unlike the Tks4/
Src-MEFs rescued with Tks4-GFP. These data are consistent
with a unique role for Tks4 in recruiting and/or activating
proteases at podosomes. The podosome protein cortactin
has recently been implicated in the secretion of matrix met-
alloproteases. We tested whether Tks4 was also involved in
the secretion of the gelatinases MMP2 and MMP9, by using
gelatin zymography of conditioned medium, but we could
detect no major differences between the Tks4 null cells and
those rescued with Tks4 (Figure 7). Another metallopro-
tease, MT1-MMP, is a key podosome/invadopodia protease
that is known to be involved in the control of matrix degra-
dation, perhaps directly or perhaps through activation of
MMP2 and MMP9 (Artym et al., 2006). In Src-3T3 cells, most
MT1-MMP is on intracellular membranes, but using confo-
cal microscopy we could detect that is was also associated
with podosome rosettes, as defined by Tks5 staining. How-
ever, we could detect no colocalization of Tks5 and MT1-
MMP in the Tks4 null cells (Figure 7), suggesting that one
role of Tks4 is to recruit MT1-MMP to podosomes.
We identified Tks4 as a Src substrate; therefore, it was of
interest to determine whether the tyrosine phosphorylation
sites of Tks4 played any role in podosome formation and/or
function. Because a lentivirus expressing the triple tyrosine
mutant (Y25/373/508F) was not available, we used trans-
fection to introduce either the wild-type or the triple ty-
rosine mutant into Tks4/ Src-MEFs. One disadvantage of
Figure 6. Tks5 expression in Tks4 null Src-MEFs res-
cues podosome formation, but not function. (A) Src-
transformed Tks4/ MEFs were plated on Oregon
Green 488 gelatin-coated coverslips for 4 h and then
fixed and F-actin visualized with phalloidin staining. (B)
Src-transformed Tks4/ MEFs were infected with len-
tivirus encoding Tks4-GFP, plated overnight on glass
coverslips, and fixed and stained with phalloidin. White
arrows point to examples of rosettes of podosomes.
Podosome function (bottom) was investigated by plat-
ing cells on Oregon Green 488 gelatin-coated coverslips
for 4 h. These cells were fixed in methanol (to denature
the GFP and allow visualization of Oregon Green) and
stained with anti-GFP antibody to visualize the infected
cells. Bars, 50 M. (C) Src-transformed Tks4/ MEFs
were infected with lentivirus encoding Tks5-GFP and
processed as described in B.
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this approach is that only later passage MEFs are able to
withstand transfection reagents. And we have found that
during continued passage of the null MEFs the level of Tks5
becomes up-regulated and podosomes begin to reform, al-
though importantly matrix degradation is never recovered.
We therefore could not quantitate the effect of the triple
mutant on podosome formation, although subjectively we
did observe increased rosette formation in the transfected
cells. We could quantitate matrix degradation ability, how-
ever, and we found that although 78% of the cells trans-
fected with wild-type Tks4 degraded matrix, only 29% of the
triple mutant-transfected cells were competent for matrix
degradation (Figure 8).
DISCUSSION
In this report, we describe the identification and initial char-
acterization of the adaptor protein Tks4, a close relative of
the previously described protein Tks5. Like Tks5, Tks4 is
broadly expressed, localizes to podosomes of Src-trans-
formed cells, and is required for podosome formation and
function. The PX domain of Tks4 has a very similar binding
specificity to Tks5 when measured in vitro, and each of the
SH3 domains of Tks4 share high sequence identity with four
of the SH3 domains of Tks5. The most obvious differences
between the two proteins lie in the linker sequences that
connect the SH3 domains, and in the Src phosphorylation
sites. For Tks4, the linker sequences are highly conserved
between mouse and human. However, when this analysis is
extended to the zebrafish Tks4 gene, the extent of sequence
similarity is much lower. Most of the conserved stretches of
sequence in the linkers between the second and third, and third
and fourth SH3 domains are proline rich, and they likely
represent binding sites for SH3 domain-containing proteins.
We used site-directed mutagenesis of candidate residues
to map putative Src phosphorylation sites on human Tks4.
One of these sites, Tyr25, which was also detected by Phos-
phosite, is in the PX domain, and another, Tyr373, is at the
beginning of the third SH3 domain. Both of these sites are
conserved in D. rerio. The third tyrosine phosphorylation
site was mapped to Tyr508, in the linker between the third
and fourth SH3 domains, and a canonical Src phosphoryla-
tion and binding site. Remarkably, this is the only tyrosine
residue in any of the linker sequences of Tks4 (in total, 600
amino acids), and it is present in the mouse and human
sequences, but not in zebrafish. Our analyses suggest that
these tyrosines are required for Tks4 function in podosomes,
but it remains to be determined whether it is phosphoryla-
tion of these residues which modified function, or whether
the amino acid substitution compromised structural integ-
rity. It will also be important to determine whether, and
under what conditions, and on which sites, Tks4 is tyrosine
phosphorylated in vivo, whether it is a direct substrate of
Src, as well as to identify associated proteins.
Like Tks5, we found that the majority of Tks4 had a cyto-
plasmic distribution in normal fibroblasts. The PX domain of
Tks4 is able to bind to PI 3-P, which is found on endosomes
(Gillooly et al., 2000); yet, only a few cells showed punctate
staining that might be consistent with endosomal association.
This suggests that the PX domain is not normally available for
association with lipids, perhaps because of intramolecular con-
straints. For example, the PX domain of Tks4 has a proline-rich
motif that might cause its association with one of its own SH3
domains. Intramolecular constraints have been shown to occur
in the distantly related protein p47phox; in this case, serine
phosphorylation of carboxy-terminal sequences renders the
amino terminal PX domain competent to bind lipids (Babior,
2002). Because the PX domain of Tks4 can be tyrosine phos-
phorylated, it will be interesting in the future to determine
whether tyrosine phosphorylation plays a role in the lipid
binding or subcellular localization of Tks4.
The most intriguing finding that we report here is that in
the absence of Tks4, podosome formation is not complete.
Thus, we detected several known podosome proteins colo-
calized in membrane puncta, but these structures were not
associated with filamentous actin. A recent study demon-
strated that podosome formation in Src-transformed cells
starts with the recruitment of a Tks5/Grb2 complex to sites
of PI 3,4P2 accumulation near focal adhesions. This then
results in the recruitment of N-WASp to Tks5 and subse-
quent actin accumulation (Oikawa et al., 2008). Our studies
show that Tks5 is present in the rudimentary structures
present in Tks4/ cells, yet actin does not accumulate,
suggesting that this model is oversimplified. Actin polymer-
ization does occur when Tks5 is overexpressed in Tks4/
cells, consistent with a hypothesis that under normal cir-
cumstances both Tks4 and Tks5 are required for filamentous
actin to form, but higher than normal levels of Tks5 can
substitute for Tks4. In keeping with this, we have noticed
that as the Tks4/ Src-MEFs are passaged in culture, full
podosome formation begins to reappear, coincident with an
up-regulation of the level of Tks5 (Buschman and Courtnei-
dge, unpublished observations). We propose that Tks5 can
indirectly and directly recruit several proteins, including
vinculin and cortactin, which together form a “pre-podo-
some.” The presence of Tks4 is then required to stimulate
actin polymerization.
Figure 7. Proteolytic activity of Tks4 null and Tks4 wild-type Src-
MEFs. (A) Conditioned media from Src-transformed Tks4/,
Tks4/, and Tks4-GFP expressing Tks4/ MEFs were collected and
assayed for gelatinase activity. (B) Src-transformed Tks4/ MEFs
were plated on glass coverslips for 20 h, fixed, and stained for MT1-
MMP and Tks5, and visualized by confocal microscopy. (C) Src-trans-
formed Tks4/ MEFs were plated on glass coverslips for 20 h, fixed,
and stained for MT1-MMP and Tks5, and visualized by confocal mi-
croscopy.
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While continued passage of, or overexpression of Tks5 in,
Tks4/ cells, resulted in the reappearance of podosomes,
neither of these conditions were sufficient to restore proteo-
lytic activity. It was recently shown that cortactin is required
for protease secretion from invadopodia. In keeping with
this, the pre-podosomes in the Tks4/ Src-MEFs contained
cortactin, and secretion of matrix metalloproteases occurred
to the same extent as the wild-type cells. Other studies have
defined “pre-invadopodia” in human cancer cells, which
contain cortactin, low levels of actin, and no MT1-MMP, a
transmembrane metalloprotease known to be required for
invasive behavior (Artym et al., 2006). Pre-podosomes have
also been described in vascular smooth muscle cells (Webb
et al., 2006). In experiments presented here, we show that
MT1-MMP is not present in the pre-podosome structures,
suggesting that Tks4 is required for its recruitment. In con-
clusion, the experiments described here reveal a role in
podosome formation and function for the new adaptor pro-
tein Tks4. Furthermore, the Tks4/ Src-MEFs should prove
a useful tool to study the sequential recruitment of podo-
some components, and the regulation of proteolytic activity.
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Figure 8. The phosphorylation sites of Tks4 are required for
podosome function. (A) Src-transformed Tks4/ MEFs were
transfected with wild-type Tks4, or the triple mutant (Y25/373/
508F), plated on Oregon Green 488 gelatin-coated coverslips for
4 h, and then fixed with methanol and stained with anti-GFP.
(B) Quantification of the degradation of gelatin per cell from the
experiment shown in A. Error bars are SEM.
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